Modeling and Simulation in Life-Sciences

FDA recently presented initiatives underway at the agency to advance the use of Modeling and Simulation.  The agency routinely advises industry on using modeling and simulation to, for example:

Predict clinical outcomes
Inform clinical trial designs
Support evidence of effectiveness
Identify the most relevant patients to study
Predict product safety

Axendia would appreciate your input on a survey that focuses on the current use and perceived value of Modeling and Simulation in Life-Sciences.

The survey should take no longer than 10 minutes to complete and all individual responses will be kept strictly confidential. You are also welcome to register to receive a copy of the survey outcome.